Zavrelova 2011.
Study characteristics | ||
Methods | Study design: retrospective cohort longitudinal Location: the Netherlands Time period: 1998 to 2005 Outcome: PDR Outcome measurement: mean, median, and percentage difference |
|
Participants | Number of participants: 3343 Diabetes type: T2D Inclusion criteria: T2D Exclusion criteria: T1D; no visit or one visit only for graded fundus photographs |
|
Notes | Link to data extraction table, risk of bias assessment, and results: osf.io/srwv8/?view_only=e42486a93e6249f080791756a0a515e0 |
|
Item | Authors' judgement | Support for judgement |
Study participation | Unclear | See ‘Notes’ above for link to risk of bias assessment |
Study attrition | No | See ‘Notes’ above for link to risk of bias assessment |
Prognostic factor measurement | Unclear | See ‘Notes’ above for link to risk of bias assessment |
Outcome measurement | Unclear | See ‘Notes’ above for link to risk of bias assessment |
Adjustment for other prognostic factors | No | See ‘Notes’ above for link to risk of bias assessment |
Statistical analysis and reporting | Unclear | See ‘Notes’ above for link to risk of bias assessment |
DM: diabetes mellitus; DBP: diastolic blood pressure; DR: diabetic retinopathy; HbA1c: glycated haemoglobin; HR: hazard ratio; IDDM: insulin‐dependent diabetes mellitus; NIDDM: non‐insulin‐dependent diabetes mellitus; NPDR: non‐proliferative diabetic retinopathy; OR: odds ratio; PDR: proliferative diabetic retinopathy; RR: risk ratio; T1D: type 1 diabetes; T2D: type 2 diabetes; WHO: World Health Organization